Journal
PERFUSION-UK
Volume 27, Issue 1, Pages 65-70Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0267659111424634
Keywords
CentriMag (R) ventricular assist system; circulatory support; right ventricular failure; centrifugal pump
Ask authors/readers for more resources
Right ventricular failure (RVF) following implantation of a left ventricular assist system (LVAS) is associated with high morbidity and mortality.(1-4) Numerous centers have reported short-term use of the CentriMag (R) Ventricular Assist System (CVAS) (Levitronix LLC, Waltham, MA) for treatment of cardiogenic shock, decompensated heart failure and right ventricular failure (RVF) following LVAS implantation.(5-9) The present report reviews the clinical course of a patient requiring long-term right ventricular support utilizing the CVAS, following a HeartMate (R) II LVAS (Thoratec Corp. Pleasanton, CA) implantation. Elevated cytotoxic antibody levels complicated the patient's treatment plan by precluding orthotropic heart transplantation. The CVAS operated for 304 days without mechanical difficulty until replaced with the HeartWare (R) Ventricular Assist System (HeartWare Inc. Miramar, FL).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available